Table 1.
Demographic, clinical, and provider characteristics of patients with low- and intermediate-risk prostate cancer initially managed with observation.
|
Diagnosis Period 2004–2009 |
Diagnosis Period 2010–2014 |
P for χ2 | |||||
|---|---|---|---|---|---|---|---|
| n | % | n | % | ||||
| Total | 2156 | 8483 | |||||
| Risk group | |||||||
| Low | 334 | 15 | 4505 | 53 | <0.001 | ||
| Intermediate | 1822 | 85 | 3978 | 47 | |||
| Age at diagnosis (years) | |||||||
| 66–69 | 359 | 17 | 2592 | 31 | <0.001 | ||
| 70–74 | 556 | 26 | 2884 | 34 | |||
| 75–79 | 558 | 26 | 1912 | 23 | |||
| 80–84 | 490 | 23 | 797 | 9.4 | |||
| ≥85 | 193 | 9.0 | 298 | 3.5 | |||
| Race | |||||||
| Non-Hispanic white | 1708 | 79 | 6895 | 81 | <0.001 | ||
| Black | 236 | 11 | 759 | 8.9 | |||
| Hispanic | 115 | 5.3 | 377 | 4.4 | |||
| Asian | 71 | 3.3 | 225 | 2.7 | |||
| Other | 26 | 1.2 | 227 | 2.7 | |||
| Marital status | |||||||
| Married | 1209 | 56 | 5203 | 61 | <0.001 | ||
| Unmarried | 449 | 21 | 1436 | 17 | |||
| Unknown | 498 | 23 | 1844 | 22 | |||
| Elixhauser Index | |||||||
| 0 | 1188 | 55 | 4607 | 54 | 0.80 | ||
| 1–2 | 767 | 36 | 3075 | 36 | |||
| ≥3 | 201 | 9.3 | 801 | 9.4 | |||
| Frail | |||||||
| No | 1927 | 89 | 7724 | 91 | 0.017 | ||
| Yes | 229 | 11 | 759 | 8.9 | |||
| Flu shot | |||||||
| No | 1183 | 55 | 4088 | 48 | <0.001 | ||
| Yes | 973 | 45 | 4395 | 52 | |||
| Medicaid enroll | |||||||
| No | 1993 | 92 | 7932 | 94 | 0.08 | ||
| Yes | 163 | 7.6 | 551 | 6.5 | |||
| Census tract poverty (%) | |||||||
| 0 -<5 | 630 | 29 | 2238 | 26 | 0.023 | ||
| 5 -<10 | 588 | 27 | 2382 | 28 | |||
| 10 -<20 | 552 | 26 | 2382 | 28 | |||
| 20 −100 | 386 | 18 | >1470 | >17 | |||
| Unknown | 0 | 0.0 | <11 | <0.1 | |||
| SEER region | |||||||
| Northeast | 451 | 21 | 1686 | 20 | <0.001 | ||
| Midwest | 264 | 12 | 954 | 11 | |||
| South | 455 | 21 | 2163 | 25 | |||
| West | 986 | 46 | 3680 | 43 | |||
| Metro | |||||||
| Metro | 1839 | 85 | 7263 | 86 | 0.71 | ||
| Non-metro | 317 | 15 | 1220 | 14 | |||
| Annual provider volume of patients with prostate cancer | |||||||
| 0–5 | 463 | 21 | 2491 | 29 | <0.001 | ||
| 6–10 | 631 | 29 | 2846 | 34 | |||
| 11+ | 1062 | 49 | 3146 | 37 | |||
Note: Percentages may not add up to 100 due to rounding.